Adjuvant transarterial chemoembolization to sorafenib in unresectable hepatocellular carcinoma: A meta-analysis.

Anxin Chen Shijie Li Zhiyuan Yao Jiahao Hu Jiasheng Cao Win Topatana Sarun Juengpanic Hong Yu Jiliang Shen Ming-Yu Chen

Published in: Journal of gastroenterology and hepatology (2020)

This meta-analysis demonstrated that TACE plus sorafenib combination therapy is superior to sorafenib monotherapy and should be recommended as an optimal treatment choice for unresectable HCC.

Keyphrases

combination therapy
liver metastases
systematic review
locally advanced
radiofrequency ablation
early stage
meta analyses
squamous cell carcinoma
clinical trial